Fulltext search has been disabled for Key Event Relationships (KERs) at this time. If you need this feature, send an email to aopwiki@googlegroups.com

Queries Key Event Relationship (KER) titles
Filter by Upstream Key Event title
Filter by Downstream Key Event title
Filter by AOP title

Showing 2876 to 2900 of 3081 KERs

Clear Table Filters
ID Upstream Event Downstream Event Creation Date Last Updated AOPs
683 669: Reduction, Neuronal synaptic inhibition 682: Generation, Amplified excitatory postsynaptic potential (EPSP) Nov 29, 2016 May 15, 2018
1018 981: Reduction, NFAT/AP-1 complex formation 982: Suppression, Suppression in mixed lymphocyte reaction (MLR) Nov 29, 2016 Dec 3, 2016 None
1019 981: Reduction, NFAT/AP-1 complex formation 983: Suppression, Suppression of T-cell dependent antibody response (TDAR) Nov 29, 2016 Dec 3, 2016 None
1020 981: Reduction, NFAT/AP-1 complex formation 984: Impairment, T-cell dependent antibody response Nov 29, 2016 Dec 3, 2016 None
1021 981: Reduction, NFAT/AP-1 complex formation 985: Relief, Relief of atopic dermatitis Nov 29, 2016 Dec 3, 2016 None
1022 981: Reduction, NFAT/AP-1 complex formation 986: Impairment of TDAR Nov 29, 2016 Dec 3, 2016 None
1256 981: Reduction, NFAT/AP-1 complex formation 1203: Suppression, Suppression of production of cytotoxic T-cells Nov 29, 2016 Dec 3, 2016 None
1257 981: Reduction, NFAT/AP-1 complex formation 1204: Suppression, Suppression of T-cell dependent antibody production Nov 29, 2016 Dec 3, 2016 None
1509 981: Reduction, NFAT/AP-1 complex formation 1202: Suppression, IL-2 and IL-4 production May 19, 2017 Jun 27, 2021
252 219: Reduction, Plasma 17beta-estradiol concentrations 285: Reduction, Vitellogenin synthesis in liver Nov 29, 2016 Mar 20, 2017
253 219: Reduction, Plasma 17beta-estradiol concentrations 309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development Nov 29, 2016 Nov 29, 2016 None
392 219: Reduction, Plasma 17beta-estradiol concentrations 405: disrupted, ovarian cycle Nov 29, 2016 Dec 3, 2016
1386 219: Reduction, Plasma 17beta-estradiol concentrations 221: Reduction, Plasma vitellogenin concentrations Mar 17, 2017 Oct 18, 2018
2922 219: Reduction, Plasma 17beta-estradiol concentrations 2139: Reduction, the ratio of E2/11-KT in plasma May 22, 2023 May 22, 2023
255 221: Reduction, Plasma vitellogenin concentrations 309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development Nov 29, 2016 Mar 20, 2017
1769 221: Reduction, Plasma vitellogenin concentrations 78: Reduction, Cumulative fecundity and spawning Sep 18, 2018 Sep 18, 2018
1882 221: Reduction, Plasma vitellogenin concentrations 1618: Reduction, egg production and spawning Apr 18, 2019 Apr 18, 2019 None
1987 1692: Reduction, Progesterone synthesis 1693: Decreased, Progesterone levels Oct 3, 2019 Oct 3, 2019
1989 1694: Reduction, progesterone uptake, decresed maturation 1695: Impaired ovulation Oct 3, 2019 Oct 3, 2019
268 243: Reduction, Prostaglandin E2 concentration 119: N/A, Gap Nov 29, 2016 Dec 3, 2016
302 274: Reduction, Testosterone synthesis by ovarian theca cells 3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells Nov 29, 2016 Mar 20, 2017
439 413: Reduction, Testosterone synthesis in Leydig cells 446: Reduction of testosterone Nov 29, 2016 Dec 2, 2016 None
2125 413: Reduction, Testosterone synthesis in Leydig cells 1690: Decrease, circulating testosterone levels May 11, 2020 May 1, 2024
2923 2139: Reduction, the ratio of E2/11-KT in plasma 221: Reduction, Plasma vitellogenin concentrations May 22, 2023 May 22, 2023
3393 2139: Reduction, the ratio of E2/11-KT in plasma 2137: Increase, Gonadotropins concentration in plasma Nov 16, 2024 Nov 16, 2024